Literature DB >> 7856857

Comparative binding studies of cyclophilins to cyclosporin A and derivatives by fluorescence measurements.

H Husi1, M G Zurini.   

Abstract

The interaction of cyclosporin A and cyclosporin derivatives with cyclophilins A, B, and C has been investigated by means of fluorescence measurement techniques. Since Trp-121 of cyclophilin A is in close contact with bound cyclosporins and changes its fluorescence emission upon binding, direct estimation of Kd values for cyclosporins is straightforward in this case. Cyclophilins B and C, however, display no evident binding-dependent fluorescence changes suitable for the estimation of their binding affinities. This problem can be circumvented by measuring the variations of fluorescence emission intensities of a mixture of cyclophilin A and the fluorescence measurements unsuitable for cyclosporin binder as a function of ligand concentration. Application of a mixed-mode kinetic analysis then allows the calculation of the cyclosporin binding affinity of the second binder in the system. The dissociation constant for cyclosporin A/cyclophilin A was found to be 36.8 nM. Mixed-mode kinetic calculations yielded Kd values of 9.8 and 90.8 nM for cyclophilins B and C, respectively. The analysis was extended to noncyclophilin (weak) cyclosporin binders such as calmodulin and actin, resulting in approximate Kd values of 1.2 and 5.7 microM, respectively. Using the same approach, the Kd values of a series of different cyclosporin derivatives were determined.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7856857     DOI: 10.1006/abio.1994.1481

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  9 in total

Review 1.  Lacritin and the tear proteome as natural replacement therapy for dry eye.

Authors:  Roy Karnati; Diane E Laurie; Gordon W Laurie
Journal:  Exp Eye Res       Date:  2013-06-12       Impact factor: 3.467

2.  Comparative Analysis of Mass-Spectrometry-Based Proteomic Methods for Protein Target Discovery Using a One-Pot Approach.

Authors:  Aurora Cabrera; Nancy Wiebelhaus; Baiyi Quan; Renze Ma; He Meng; Michael C Fitzgerald
Journal:  J Am Soc Mass Spectrom       Date:  2019-11-22       Impact factor: 3.109

Review 3.  Molecular aspects of cyclophilins mediating therapeutic actions of their ligands.

Authors:  Andrzej Galat; Jacqueline Bua
Journal:  Cell Mol Life Sci       Date:  2010-07-04       Impact factor: 9.261

4.  Efficient soluble expression of active recombinant human cyclin A2 mediated by E. coli molecular chaperones.

Authors:  Asterios I Grigoroudis; Campbell McInnes; Padmavathy Nandha Premnath; George Kontopidis
Journal:  Protein Expr Purif       Date:  2015-05-06       Impact factor: 1.650

5.  Characterization of folding cores in the cyclophilin A-cyclosporin A complex.

Authors:  Jack W Heal; Stephen A Wells; Claudia A Blindauer; Robert B Freedman; Rudolf A Römer
Journal:  Biophys J       Date:  2015-04-07       Impact factor: 4.033

6.  Thermo-kinetic analysis space expansion for cyclophilin-ligand interactions - identification of a new nonpeptide inhibitor using Biacore™ T200.

Authors:  Martin A Wear; Matthew W Nowicki; Elizabeth A Blackburn; Iain W McNae; Malcolm D Walkinshaw
Journal:  FEBS Open Bio       Date:  2017-02-23       Impact factor: 2.693

7.  One novel quinoxaline derivative as a potent human cyclophilin A inhibitor shows highly inhibitory activity against mouse spleen cell proliferation.

Authors:  Jian Li; Jing Chen; Li Zhang; Feng Wang; Chunshan Gui; Li Zhang; Yu Qin; Qiang Xu; Hong Liu; Fajun Nan; Jingkang Shen; Donglu Bai; Kaixian Chen; Xu Shen; Hualiang Jiang
Journal:  Bioorg Med Chem       Date:  2006-05-06       Impact factor: 3.641

8.  Novel cyclophilin D inhibitors derived from quinoxaline exhibit highly inhibitory activity against rat mitochondrial swelling and Ca2+ uptake/ release.

Authors:  Hong-xia Guo; Feng Wang; Kun-qian Yu; Jing Chen; Dong-lu Bai; Kai-xian Chen; Xu Shen; Hua-liang Jiang
Journal:  Acta Pharmacol Sin       Date:  2005-10       Impact factor: 6.150

9.  Cyclophilin A protects HIV-1 from restriction by human TRIM5α.

Authors:  Kyusik Kim; Ann Dauphin; Sevnur Komurlu; Sean M McCauley; Leonid Yurkovetskiy; Claudia Carbone; William E Diehl; Caterina Strambio-De-Castillia; Edward M Campbell; Jeremy Luban
Journal:  Nat Microbiol       Date:  2019-10-21       Impact factor: 17.745

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.